Status:
COMPLETED
Malaria Prevalence in Children
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Plasmodium Falciparum Malaria
Eligibility:
All Genders
6-10 years
Brief Summary
The purpose of this pilot study is to evaluate the use of (1) 'malaria prevalence', (2) 'malaria incidence' and (3) 'malaria mortality' as a measure of malaria transmission in The Gambia, while mosqui...
Detailed Description
Malaria remains one of the world's greatest childhood killers and is a substantial obstacle to social and economic development in the tropics. The overwhelming bulk of the world's malaria burden rests...
Eligibility Criteria
Inclusion
- All children living in the defined areas for intervention and between the age of 6 months and 10 years will be invited to participate. No distinctions will be made regarding gender or ethnic group. Moreover, as the target population is all people living in the areas of intervention, and in order of the results from this study to be as generalizable as possible, no distinctions will be made in terms of medical condition or physical health. Moreover, we believe that any children with a medical condition would be especially favored by the participation in the study.
Exclusion
- None
Key Trial Info
Start Date :
June 7 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2009
Estimated Enrollment :
2552 Patients enrolled
Trial Details
Trial ID
NCT00322816
Start Date
June 7 2006
End Date
March 31 2009
Last Update
February 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Research Council's Laboratories
Fajara, The Gambia